Larvol Delta - BioInvent-Reports-Promising-Data-from-Ongoing-Phase-2a-study-for-BI1808-with-KEYTRUDA-pembrolizumab-in-Recurrent-Ovarian-Cancer

BI-1808 - BioInvent

https://finance.yahoo.com/news/bioinvent-reports-promising-data-ongoing-064500783.html

Jan 5, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next